Zoetis Appoints Glenn David As Acting CFO

(RTTNews) - Zoetis Inc. (ZTS) announced that Glenn David, senior vice president of Finance Operations, has been appointed as acting Chief Financial Officer, and will assume responsibility for the oversight of the company's financial management and global operations, effective immediately.

David will succeed Executive Vice President and Chief Financial Officer Richard Passov, who will be leaving the company at the end of April.

David has more than 20 years of experience in finance and operations - including roles at Pfizer, Bankers Trust, Paine Webber and Credit Suisse. David has played a key role in leading the financial operations for Zoetis since its Initial Public Offering, including financial planning, analysis and support across its 70 global markets. Most recently, David has served as senior vice president of Finance Operations for Zoetis.

Before the Zoetis IPO, David served in various financial roles at its former parent company Pfizer, including vice president of Global Finance for Pfizer Animal Health and vice president of Finance for the U.S. Primary Care franchise. David also played important financial roles in Pfizer's integrations of the Pharmacia, Wyeth and King Pharmaceuticals' acquisitions.

Before joining to Pfizer in 1999, David gained valuable financial experience at Bankers Trust, Paine Webber and Credit Suisse.